Biographical Sketch
Aaron Brzezinski, MD, was born in Mexico City and attended medical school at the Universidad Nacional Autonoma de Mexico, receiving his degree in medicine in 1981. He performed his postgraduate training in internal medicine at Hospital Espanol in Mexico City. Dr. Brzezinski moved to Toronto, Canada, to continue training with a residency in internal medicine and a fellowship in gastroenterology. He performed research for one year with Dr. Nicholas Diamant, and completed a special fellowship in inflammatory bowel disease and performed clinical research under Dr. Kursheed Jeejeebhoy and Dr. Jeffrey Baker at the University of Toronto.
Dr. Brzezinski is certified in internal medicine and in Gastroenterology in Canada and the United States, and in 1992 started to work in the Department of Gastroenterology and Hepatology at Cleveland Clinic as Assistant Staff. In 1994, he became a Staff Gastroenterologist.
Through the years, Dr. Brzezinski has been either principal investigator or sub-investigator in numerous clinical trials and has published in peer-reviewed journals and written numerous book chapters. He has lectured extensively within the United States and internationally in Argentina, Brazil, Chile, Dominican Republic, Ecuador, Guatemala, Mexico, Spain and Turkey.
Dr. Brzezinski actively participates in teaching medical students, residents and fellows. His clinical practice is almost exclusively in inflammatory bowel disease, microscopic colitis and celiac disease. Besides seeing patients in the office, he also performs upper endoscopy (EGD) and colonoscopy.
Specialty Interests
celiac disease, Crohn's Disease, IBD including ulcerative colitis and crohn's, inflammatory bowel disease, Nuclear Scintigraphy for evaluation of Whole Gut Motility, Ulcerative Colitis, Eval and management of Hepatobiliary Malignancies
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with
the pharmaceutical or medical device industries to help develop
medical breakthroughs or provide medical education about recent
trends. The collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with which
they collaborate. The Cleveland Clinic requires its doctors
to approve the public disclosures of their scientific
collaborations with industry. As of 10/24/2008 the review
process regarding Dr. Brzezinski’s disclosure had not been
completed. Patients should feel free to contact their doctor
about any of the relationships and how the relationships are
overseen by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with industry
and innovation management, go to our
Integrity in Innovation page.